We care about the health and well-being of all our patients, staff, and community.Read the latest COVID-19 update
ORM Fertility
ORM Love Is Family
Sharing Healthy Genes
  • Patient Portal
  • For Providers
  • Countries
    • Australia
    • China
    • France
    • Germany
    • Israel
    • Italy
    • Japan
    • United Kingdom
    • New Zealand
    • Spain
  • About Us
    • Our Fertility Center
    • Our Embryology Lab
    • Our Providers
      • Dr. Bankowski
      • Dr. Barbieri
      • Dr. Hesla
      • Dr. Hurliman
      • Dr. Massie
      • Alexa Gilbert, CNM
      • Shannon Gwartney, MSN, WHNP-BC
      • Dr. Matteri
    • Scientific Papers & Publications
    • Press Room
    • ORM in The News
    • Careers
  • Locations
    • Downtown Portland
    • Bellevue
    • Southside Portland
    • Westside Portland
  • Fertility Care
    • Comprehensive Fertility Treatment
    • Evaluation
    • IUI – Intrauterine Insemination
    • IVC – INVOCELL
    • IVF Lite
    • IVF – In Vitro Fertilization
    • Egg Freezing
    • Fertility Preservation for Cancer
    • Genomics Program
    • Counseling
    • Integrative Medicine
      • Fertility Acupuncture
    • LGBTQ
  • Surrogacy
    • Surrogacy at ORM
    • Gestational and Traditional Surrogacy
    • Int. Legal Expert Videos
  • Donors
    • Become an Egg Donor
    • Meet Our Egg Donors
    • Egg Donor Database
    • Embryo Donation Program
    • Sperm Donors
  • Genomics
  • Success
    • Successful Outcomes
    • Our Families
    • Ratings & Reviews
  • Resources
    • Blog
    • Make a Payment
    • Financial
      • Fertility Insurance & Estimates
      • Fertility Financing
    • Forms
    • Fertility Medications
    • Learning Center
    • Glossary
    • Support Groups
    • Raising Awareness
    • Videos
    • Visit ORM
  • Events
    • Portland Fertility Seminar
    • Bellevue Fertility Seminar
    • Egg Freezing Webinar
    • Bend Fertility Seminar
    • Preconception Fertility Seminar
    • Egg Donor Chat
    • Egg Seeking Sperm Seminar
    • Donor Egg + Surrogacy Discussion
    • ORM Support Group
    • Surrogacy Webinar Series
  • Countries
    • Australia
    • China
    • France
    • Germany
    • Israel
    • Italy
    • Japan
    • United Kingdom
    • New Zealand
    • Spain

Zika Virus Awareness

Zika Virus Awareness
  • Posted On: February 3, 2016
  • Categories: Events & Announcements
  • Tags: CDC | Fertility Health | Oregon Reproductive Medicine | Prevention | Zika Virus

ORM will follow CDC guidelines and any American Society of Reproductive Medicine guidelines that are released regarding the Zika Virus.

March 4 , 2016
by: ASRM Office of Public Affairs
Published in ASRM Bulletin Volume 18, Number 13

FDA Issues New Guidance on Zika Virus, Includes Reproductive Tissues

The Food and Drug Administration (FDA) this week issued a new Guidance Document on the Zika virus. Donors considered at risk of transmitting Zika virus should be deemed ineligible.

According to the FDA press release:

“There is a potential risk that the Zika virus can be transmitted by HCT/Ps (donated tissue) used as part of a medical, surgical, or reproductive procedure. HCT/Ps  include products such as corneas, bone, skin, heart valves, hematopoietic stem/progenitor cells (HPCs), gestational tissues such as amniotic membrane, and reproductive tissues such as semen and oocytes.

According to the Centers for Disease Control and Prevention, Zika virus can be spread by a man to his sexual partners. And to date, there have been several cases of sexual transmission in the U.S. Current information about Zika virus detection in semen suggests that a period of ineligibility longer than the waiting period that has been recommended for donors of Whole Blood and blood components is necessary for HCT/P donors.

Recommendations for living donors of HCT/Ps: Donors should be considered ineligible if they were diagnosed with Zika virus infection, were in an area with active Zika virus transmission, or had sex with a male with either of those risk factors, within the past six months. Donors of umbilical cord blood, placenta, or other gestational tissues should be considered ineligible if they have had any of the above risk factors at any point during their pregnancy.”

The entire FDA press release with links to other FDA documents, can be found here

Additional informational links:

http://www.cdc.gov/zika/index.html

 http://emergency.cdc.gov/han/han00388.asp

http://www.cdc.gov/zika/pdfs/zika-pregnancytravel.pdf

http://www.cdc.gov/zika/transmission/sexual-transmission.html

Related Articles

About Megan Armand

Categories

  • All
  • Egg Donation
  • Egg Freezing
  • Events & Announcements
  • Fertility
  • Infertility Causes
  • LGBTQ
  • ORM in the Media
  • Preconception
  • Surrogacy
  • Treatments

Contact ORM Fertility for more information today.

Connect With Us

 ORM Fertility

Providing world-class delivery of reproductive and genomic medicine
in the most caring environment, while remaining accessible to individuals and families
who want to become parents.


ORM Genetics

Recent Posts

December 3, 2020 | Amie Northagen Sex Selection for...

Since the first successful In Vitro Fertilization (IVF) live birth in 1978, the technology behind infertility treatment has helped millions of couples and individuals grow...

October 16, 2020 | Sarah Newsum Understanding Your...

Understanding Your Ovarian Reserve & The Egg Retrieval Process

May 1, 2020 | Sarah Newsum Non-emergency medical,...

Non-emergency medical, dental procedures resume in Oregon

Connect

  • Downtown Fertility Center
    808 SW 15th Ave
    Portland, Oregon 97205
  • Westside Fertility Center
    9555 SW Barnes Road, Suite 390
    Portland, OR USA 97225
  • Southside Fertility Center
    12115 SW 70th Ave, Suite 101
    Portland, Oregon 97223
  • Bellevue Fertility Center
    1370 116th Ave NE Suite 100
    Bellevue, Washington 98004
  • Phone: 877.567.4994 or
    503.274.4994
    Fax: 503.274.4946
  • [email protected]

Follow Us

Newsletter

© 2021 ORM Fertility, All Rights Reserved | Privacy Policy